The Discounted Cash Flow (DCF) valuation of Surgical Science Sweden AB (SUS.ST) is 84.71 SEK. With the latest stock price at 151.90 SEK, the upside of Surgical Science Sweden AB based on DCF is -44.2%.
Based on the latest price of 151.90 SEK and our DCF valuation, Surgical Science Sweden AB (SUS.ST) is a sell. selling SUS.ST stocks now will result in a potential gain of 44.2%.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 8.0% | 6.7% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 55.36 - 262.63 | 84.71 |
| Upside | -63.6% - 72.9% | -44.2% |